Loading...
OTCM
RMHI
Market cap22mUSD
Oct 08, Last price  
0.89USD
1D
0.00%
1Q
-1.63%
Jan 2017
2,113.38%
IPO
19.64%
Name

Peak Pharmaceuticals Inc

Chart & performance

D1W1MN
OTCM:RMHI chart
P/E
—
P/S
—
EPS
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Peak Pharmaceuticals, Inc., an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions. Originally established in 2007 as Cannabis Therapy Corporation, the company rebranded to Peak Pharmaceuticals, Inc. in December 2014 and maintains its main office in Scottsdale, Arizona.

Key people

Chief Executive Officer, Chief Financial Officer, Director · since 2016
IPO date
May 17, 2010
Employees
1
Domiciled in
US
Incorporated in
US
Legal address
C/O Nevada Agency and Transfer Company
50 West Liberty Street
Suite 880
Reno, NV 89501
US
Headquarters
C/O Gottbetter & Partners, LLP
12th Floor
488 Madison Avenue
New York, NY 10022
US
Previous name
Cannabis Therapy Corp.
Previous name
Frac Water Systems, Inc.

Valuation

No data to show